Good to see you again. We hope the start of your week went well. As always, there is much to do. We expect to have an interesting item for your later. Meanwhile, we must hurry one of the short people off to school and tend to the official Pharmalot mascot - our pooch. So please take a peek at these developments. And, of course, don't forget to enjoy that cup of stimulation or bottle of water...
FDA To Decide On Glaxo & Pozen's Migraine Drug (Yahoo/AP)
Roche To Pay $160M For UK's Piramed (Yahoo/Reuters)
Shire To Shift Tax Base To Ireland (Bloomberg News)
Genentech's Rituxan Fails As Treatment For PPMS (PharmaTimes)